检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:潘阳彬[1] 万建新[1] 谢良地[1] 许昌声[1]
机构地区:[1]福建医科大学附属第一医院肾内科,福建福州350005
出 处:《中国现代医学杂志》2008年第19期2805-2808,2812,共5页China Journal of Modern Medicine
基 金:福建省教育厅科研基金资助项目(No:JA03102)
摘 要:目的观察阿托伐他汀在肾大部切除大鼠模型中对残肾的保护作用并探讨其可能的机制。方法将32只大鼠随机分为4组,每组8只:假手术组、肾大部切除组、肾大部切除加小剂量阿托伐他汀组及大剂量阿托伐他汀组。8周后检测大鼠尿蛋白、肾功能和血脂;观察肾脏病理的改变;免疫组化检测FN在肾组织中的表达;并用RT-PCR测定肾组织中TGF-β1、CTGF和PAI-1mRNA的表达。结果治疗组大鼠尿蛋白定量、血BUN、Scr降低,FN表达下降,肾组织TGF-β1、CTGF和PAI-1mRNA的表达也下降,与肾大部切除组比较差异有显著性(P<0.01,P<0.05)。各组血脂水平无明显差异(P>0.05)。治疗组呈剂量依赖性使肾大部切除大鼠肾小球系膜细胞增生受抑制,肾组织胶原纤维沉积减少。结论阿托伐他汀可降低肾大部切除大鼠血BUN、Scr、尿蛋白,可抑制肾小球系膜细胞增生,减少系膜基质蓄积,且与血脂水平的改变无关,其肾脏保护作用可能与抑制肾组织CTGF、TGF-β1和PAI-1的表达有关。[Objective] To investigate the nephroprotective effects of Atorvastatin on rats with subtotal renal ablation and its mechanism. [Methods] 32 Rats were assigned to four groups with 8 animals in each group: SHAM group, SNX group, LD group, and HD group. The urinary protein, BUN, Ser, serum total cholesterol, triglycerides and LDL were measured after 8 weeks. The expression of FN were detected immunohistochemicaUy. The expression of TGF-β1, CTGF and PAI-1 were detected by way of RT-PCR. [Results] After treatment with Atorvastafin, pro-teinuria, BUN and SCr in group LD and group HD were reduced in contrast to the group SNX (P〈0.01, P 〈0.05). There were no significant changes in serum total CHOL, TG and LDL among the four groups (P 〉0.05). Pathohisto-logical study revealed that there were less glomerular matris, collagen and fibroneetin in Atorvastatin treatment groups compared with the SNX group. There were less FN in two therapy groups than those in SNX group. Renal TGF-β1, CTGF and PAI-1 mRNA expression were markedly reduced in a dose-dependent manner in two therapy groups compared with the SNX group. [Conclusions] The urinary protein excretion,BUN and Scr in 5/6 nephrec-tomized rats were maybe decreased by Atorvastatin. And the renoprotective effect does not correlate with the change in serum lipid.Atorvastatin can rehve the glomerular sclerosis. This renoprotective effect may be attributed to inhibiting the expression of TGF-β1 , CTGF and PAI-1.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.80